• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将终末期疾病路径上死亡的患者比例用作质量指标的使用:解释方面的考虑。

Use of the proportion of patients dying on an End of Life Pathway as a quality marker: considerations for interpretation.

机构信息

Palliative Care, University of Teesside, Middlesbrough, UK.

出版信息

Palliat Med. 2010 Jul;24(5):544-7. doi: 10.1177/0269216310368579. Epub 2010 May 25.

DOI:10.1177/0269216310368579
PMID:20501514
Abstract

The Department of Health as part of its End of Life Care Strategy has developed a set of markers as a quality of care proxy for adults at the end of life. 'The number/proportion of patients dying with the Liverpool Care Pathway (or equivalent) in place' is suggested as a quality metric for all care providers. A retrospective audit of uptake of use of the Liverpool Care Pathway (LCP) in an NHS hospital in the North of England showed that 39% of all patients who died had been placed on the LCP. Overall 58% of patients who died were judged to meet the criteria for LCP use. This represented 81% of patients dying with cancer as a primary cause compared to 51% of patients dying with non-cancer. This difference was statistically very significant. In the Trust under study, 67% of dying patients who fulfilled the LCP criteria were placed on the pathway. The results of this study suggest that a simple percentage of deaths on the pathway is an unsophisticated statistic which needs to be interpreted with care. In particular it will be influenced by the proportion of people dying with cancer or non-cancer. This should be considered particularly when presenting the results to the public and to healthcare stakeholders or when making comparisons between provider organizations.

摘要

卫生部作为其生命末期关怀策略的一部分,已经制定了一系列标志,作为生命末期成年人护理质量的代理指标。“在所有护理提供者中,建议将使用利物浦关怀路径(或同等路径)的患者数量/比例作为质量指标。”对英格兰北部一家 NHS 医院使用利物浦关怀路径(LCP)的回顾性审计显示,所有死亡患者中有 39%被安置在 LCP 上。总体而言,58%的死亡患者被认为符合 LCP 使用标准。这代表了作为主要原因死亡的癌症患者的 81%,而死于非癌症的患者为 51%。这一差异具有统计学意义。在所研究的信托中,67%符合 LCP 标准的临终患者被安置在该路径上。这项研究的结果表明,单纯的路径上的死亡百分比是一种不够复杂的统计数据,需要谨慎解释。特别是,它将受到癌症或非癌症患者死亡比例的影响。在向公众和医疗保健利益相关者展示结果或在提供者组织之间进行比较时,应特别考虑这一点。

相似文献

1
Use of the proportion of patients dying on an End of Life Pathway as a quality marker: considerations for interpretation.将终末期疾病路径上死亡的患者比例用作质量指标的使用:解释方面的考虑。
Palliat Med. 2010 Jul;24(5):544-7. doi: 10.1177/0269216310368579. Epub 2010 May 25.
2
Introduction of the Liverpool Care Pathway for end of life care to emergency medicine.引入利物浦临终关怀路径(Liverpool Care Pathway)至急诊医学。
Emerg Med J. 2009 Nov;26(11):777-9. doi: 10.1136/emj.2008.067249.
3
Improving end-of-life care: development and pilot-test of a clinical pathway.改善临终关怀:临床路径的制定与试点测试
J Pain Symptom Manage. 2005 Jun;29(6):529-43. doi: 10.1016/j.jpainsymman.2004.05.011.
4
The Liverpool Care Pathway: does it improve quality of dying? [corrected].利物浦临终关怀路径:它能提高临终质量吗?[已修正]
Br J Nurs. 2011;20(15):942-6. doi: 10.12968/bjon.2011.20.15.942.
5
End-of-life decision making for cancer patients in different clinical settings and the impact of the LCP.不同临床环境下癌症患者的临终决策和 LCP 的影响。
J Pain Symptom Manage. 2010 Jan;39(1):33-43. doi: 10.1016/j.jpainsymman.2009.05.018. Epub 2009 Nov 4.
6
[Care of the dying in the hospital: initial experience with the Liverpool Care Pathway (LCP) in Germany].[医院中的临终关怀:德国利物浦临终关怀路径(LCP)的初步经验]
Dtsch Med Wochenschr. 2009 Jul;134(27):1399-404. doi: 10.1055/s-0029-1225295. Epub 2009 Jun 23.
7
Care of the dying: what a difference an LCP makes!临终关怀:利物浦护理路径能带来多大的改变!
Palliat Med. 2007 Jul;21(5):365-8. doi: 10.1177/0269216307081117.
8
Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life.生命最后一年中呼吸系统疾病患者在医疗保健利用和死亡地点方面的城乡差异。
Rural Remote Health. 2010 Apr-Jun;10(2):1349. Epub 2010 Apr 30.
9
Quality of dying in head and neck cancer patients: a retrospective analysis of potential indicators of care.头颈部癌症患者的临终质量:对潜在护理指标的回顾性分析
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Aug;100(2):147-52. doi: 10.1016/j.tripleo.2004.11.011.
10
Evaluating the role and value of a national office to coordinate Liverpool Care Pathway implementation in New Zealand.评估国家办事处在协调新西兰利物浦护理路径实施方面的作用和价值。
Int J Evid Based Healthc. 2011 Sep;9(3):252-60. doi: 10.1111/j.1744-1609.2011.00219.x.

引用本文的文献

1
Standardising care of the dying: An ethnographic analysis of the Liverpool Care Pathway in England and the Netherlands.规范临终关怀:英格兰和荷兰利物浦关怀路径的民族志分析。
Sociol Health Illn. 2022 Nov;44(9):1445-1460. doi: 10.1111/1467-9566.13529. Epub 2022 Aug 19.
2
Variation in medication use in cancer patients at the end of life: a cross-sectional analysis.癌症患者生命末期的药物使用变化:一项横断面分析。
Support Care Cancer. 2013 Apr;21(4):1003-11. doi: 10.1007/s00520-012-1619-0. Epub 2012 Oct 14.
3
Why is the Liverpool care pathway used for some dying cancer patients and not others? Healthcare professionals' perspectives.
为什么利物浦护理路径适用于一些临终癌症患者而不适用于其他患者?医疗保健专业人员的观点。
BMC Res Notes. 2012 Sep 24;5:524. doi: 10.1186/1756-0500-5-524.